NRBO Old Analysis

NRBODelisted Stock  USD 1.89  0.11  5.50%   
NRBO Old is overvalued with Real Value of 1.73 and Hype Value of 1.87. The main objective of NRBO Old delisted stock analysis is to determine its intrinsic value, which is an estimate of what NRBO Old is worth, separate from its market price. There are two main types of NRBO Old's stock analysis: fundamental analysis and technical analysis.
The NRBO Old stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. NRBO Old is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. NRBO Stock trading window is adjusted to America/New York timezone.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

NRBO Stock Analysis Notes

About 65.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.57. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NRBO Old recorded a loss per share of 4.29. The entity last dividend was issued on the 31st of December 2019. The firm had 1:8 split on the 21st of December 2023. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts. Neurobo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. To find out more about NRBO Old contact HyungHeon Kim at 857 702 9600 or learn more at https://www.neurobopharma.com.

NRBO Old Investment Alerts

NRBO Old is now traded under the symbol MTVA. Please update your portfolios or report it if you believe this is an error. Report It!
NRBO Old is not yet fully synchronised with the market data
NRBO Old had very high historical volatility over the last 90 days
NRBO Old may become a speculative penny stock
NRBO Old has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 7 K. Net Loss for the year was (12.47 M) with profit before overhead, payroll, taxes, and interest of 0.
NRBO Old currently holds about 8.85 M in cash with (10.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 65.0% of the company outstanding shares are owned by corporate insiders

NRBO Old Upcoming and Recent Events

Earnings reports are used by NRBO Old to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
4th of April 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

NRBO Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.33 M.

NRBO Old Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NRBO Old insiders, such as employees or executives, is commonly permitted as long as it does not rely on NRBO Old's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NRBO Old insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Strickland D Gordon over three months ago
Acquisition by Strickland D Gordon of 12500 shares of Neurobo Pharmaceuticals subject to Rule 16b-3
 
Oh Jeong Gyun over three months ago
Insider Trading
 
Dong-a St Co., Ltd over six months ago
Acquisition by Dong-a St Co., Ltd of 2544530 shares of Neurobo Pharmaceuticals at 3.93 subject to Rule 16b-3
 
Dong-a St Co., Ltd over six months ago
Disposition of 407 shares by Dong-a St Co., Ltd of Neurobo Pharmaceuticals at 3.75 subject to Rule 16b-3
 
Kim Hyung Heon over six months ago
Disposition of 11467 shares by Kim Hyung Heon of Neurobo Pharmaceuticals at 3.6 subject to Rule 16b-3
 
Goldman Sachs Group Inc over six months ago
Discretionary transaction by Goldman Sachs Group Inc of tradable shares of Neurobo Pharmaceuticals subject to Rule 16b-3
 
Dong-a St Co., Ltd over six months ago
Acquisition by Dong-a St Co., Ltd of 2544530 shares of Neurobo Pharmaceuticals at 3.13 subject to Rule 16b-3
 
Swirsky Douglas J over six months ago
Acquisition by Swirsky Douglas J of 60000 shares of Neurobo Pharmaceuticals at 6.04 subject to Rule 16b-3
 
Glickman Mark A over six months ago
Acquisition by Glickman Mark A of 12500 shares of Neurobo Pharmaceuticals subject to Rule 16b-3
 
Jeong Tae Heum over a year ago
Acquisition by Jeong Tae Heum of 60000 shares of Neurobo Pharmaceuticals at 8. subject to Rule 16b-3
 
Kim Hyung Heon over a year ago
Acquisition by Kim Hyung Heon of 20000 shares of Neurobo Pharmaceuticals subject to Rule 16b-3
 
Strickland D Gordon over a year ago
Acquisition by Strickland D Gordon of 20000 shares of Neurobo Pharmaceuticals subject to Rule 16b-3

NRBO Old Predictive Daily Indicators

NRBO Old intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NRBO Old stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About NRBO Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how NRBO Old prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NRBO shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as NRBO Old. By using and applying NRBO Stock analysis, traders can create a robust methodology for identifying NRBO entry and exit points for their positions.
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts. Neurobo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NRBO Old to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run ETFs Now

   

ETFs

Find actively traded Exchange Traded Funds (ETF) from around the world
All  Next Launch Module
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in NRBO Stock

If you are still planning to invest in NRBO Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NRBO Old's history and understand the potential risks before investing.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world